GENE ONLINE|News &
Opinion
Blog

Vir Biotechnology
GSK, Vir Ink Deal with Government of Singapore to Supply COVID-19 Drug Sotrovimab
2021-07-03
FDA Grants Emergency Use Authorization to Third COVID-19 Antibody Therapy
2021-05-27
Vir, GSK’s Antibody Therapy Effective Against COVID-19 Variants, Reduces Hospitalization and Deaths by 85%
2021-03-11
Lilly Teams up with GSK, Vir to Fight New COVID-19 Variants Using Antibody Combo
2021-01-28
Vir Biotechnology Showcases Data on a Potential Therapy for Influenza
2020-10-24
GSK, Vir Collaboration Drives Advanced Clinical Trial for Novel COVID-19 Antibody Forward
2020-10-11
An Old SARS Antibody May Well be Our Weapon against COVID-19
2020-05-23
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
Vir Biotechnology Stocks Raise after COVID-19 Partnership with Biogen
2020-03-12
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top